CAS: 18378-89-7; Mithramycin

该化合物是细菌链球菌所生产的抗生素聚氯酸酯,其特点是结构复杂,包括四环核心和多种糖糖糖,有助于其生物活动,三氯硝基苯表现出抗沙素特性,主要是与DNA结合,抑制转录,干扰癌症细胞扩散所必需的蛋白合成,对包括睾丸癌和各种沙网在内的某些类型的肿瘤特别有效,该化合物在水中溶解性低,可能影响其生物利用率和治疗应用,而Mithramic的功能机制涉及金属离子的切热,进一步提高其干预细胞过程的能力,由于其有效作用和潜在副作用,通常保留在特定临床情况下使用,并且继续研究其在癌症治疗中的功效和安全性.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    Mithramycin Dk置于ketoreductase Mtmw体系中,化学反应生成光辉霉素
    参考文献:Molecular Insight Into Substrate Recognition And Catalysis Of Baeyer-villiger Monooxygenase Mtmoiv,The Key Frame-Modifying Enzyme In The Biosynthesis Of Anticancer Agent Mithramycin
    标题:Molecular Insight Into Substrate Recognition And Catalysis Of Baeyer-villiger Monooxygenase Mtmoiv,The Key Frame-Modifying Enzyme In The Biosynthesis Of Anticancer Agent Mithramycin
    摘要:Baeyer-Villiger Monooxygenases (Bvmos) Have Been Shown To Play Key Roles For The Biosynthesis Of Important Natural Products. Mtmoiv,A Homodimeric Fad-And Nadph-Dependent Bvmo,Catalyzes The Key Frame-Modifying Steps Of The Mithramycin Biosynthetic Pathway,Including An Oxidative C-C Bond Cleavage,By Converting Its Natural Substrate Premithramycin B Into Mithramycin Dk,The Immediate Precursor Of Mithramycin. The Drastically Improved Protein Structure Of Mtmoiv Along With The High-Resolution Structure Of Mtmoiv In Complex With Its Natural Substrate Premithramycin B Are Reported Here,Revealing Previously Undetected Key Residues That Are Important For Substrate Recognition And Catalysis. Kinetic Analyses Of Selected Mutants Allowed Us To Probe The Substrate Binding Pocket Of Mtmoiv And Also To Discover The Putative Nadph Binding Site. This Is The First Substrate-Bound Structure Of Mtmoiv Providing New Insights Into Substrate Recognition And Catalysis,Which Paves The Way For The Future Design Of A Tailored Enzyme For The Chemo-Enzymatic Preparation Of Novel Mithramycin Analogues.
    Doi:10.1021/cb400399B

    海关参考信息

    专利信息


    专利号:US-2004242897-A1
    优先权日:2002-07-31
    标题 :Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:WO-2004011474-A1
    优先权日:2002-07-31
    标题:Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-6653468-B1
    优先权日:2002-07-31
    标 题 :Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
    权利人:ISIS PHARMACEUTICALS INC
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-10973847-B2
    优先权日:2017-06-30
    标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof
    发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.
    成都曼思特生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.cdmust.com
    电话: 028-87384368👤
    📞成都曼思特生物科技有限公司 ⚠️参考联系方式

    销售电话:028-87384368
    邮箱:cdmust@163.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Portugal J. Mithramycin and its analogs: Molecular features and antitumor action. Pharmacol Ther. 2024 Aug;260:108672. doi: 10.1016/j.pharmthera.2024.108672. Epub 2024 Jun 3. 10(14):eadm7098. doi: 10.1126/sciadv.adm7098. Epub 2024 Apr 3.
    3: El-Mayet FS, Santos VC, Wijesekera N, Lubbers S, Harrison KS, Sadeghi H, Jones C. Glucocorticoid receptor and specificity protein 1 (Sp1) or Sp3, but not the antibiotic Mithramycin A, stimulates human alphaherpesvirus 1 (HSV-1) replication. Antiviral Res. 2024 May;225:105870. doi: 10.1016/j.antiviral.2024.105870. Epub 2024 Mar 29.
    4: Cao C, Xu Q, Zhu Z, Xu M, Wei Y, Lin S, Cheng S, Zhi W, Hong P, Huang X, Lin D, Cao G, Meng Y, Wu P, Peng T, Wei J, Ding W, Huang X, Sung W, Chen G, Ma D, Li G, Wu P. Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer. Cancer Lett. 2024 Apr 28;588:216809. doi: 10.1016/j.canlet.2024.216809. Epub 2024 Mar 11. 98(1):e0143623. doi: 10.1128/jvi.01436-23. Epub 2023 Dec 12.

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知